1.69
-0.04(-2.31%)
Currency In USD
Previous Close | 1.73 |
Open | 1.7 |
Day High | 1.74 |
Day Low | 1.64 |
52-Week High | 2.55 |
52-Week Low | 1.03 |
Volume | 25,144 |
Average Volume | 376,875 |
Market Cap | 12.68M |
PE | -1.46 |
EPS | -1.16 |
Moving Average 50 Days | 1.77 |
Moving Average 200 Days | 1.7 |
Change | -0.04 |
If you invested $1000 in BioRestorative Therapies, Inc. (BRTX) 10 years ago, it would be worth $0.05 as of April 25, 2025 at a share price of $1.69. Whereas If you bought $1000 worth of BioRestorative Therapies, Inc. (BRTX) shares 5 years ago, it would be worth $4,225 as of April 25, 2025 at a share price of $1.69.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
GlobeNewswire Inc.
Apr 15, 2025 12:30 PM GMT
MELVILLE, N.Y., April 15, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is plea
BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States
GlobeNewswire Inc.
Apr 10, 2025 1:15 PM GMT
MELVILLE, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is plea
BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.
Mar 27, 2025 8:05 PM GMT
MELVILLE, N.Y., March 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financi